IDL Biotech AB (IDL B):企業の財務・戦略的SWOT分析

◆英語タイトル:IDL Biotech AB (IDL B) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15138
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
IDL Biotech AB (IDL Biotech) is a biotechnology company that develops, manufactures and markets vitro diagnostic tests. The company offers products in the clinical areas of oncology and bacteriology. It offers vitro diagnostic tumor activity markers for common types of cancer which include breast, colorectal, lung, ovarian and prostate cancer. IDL Biotech offers serum and urine analysis to measure disease status in patients. The company also offers rapid Salmonella typhoid tests. It sells its products through a network of distributors in Sweden and abroad. IDL Biotech is headquartered in Stockholm City, Sweden.

IDL Biotech AB Key Recent Developments

Mar 29,2018: IDL Biotech to strengthen global sales
Mar 25,2018: IDL Biotech Gets ?Patent Approved In Europe

This comprehensive SWOT profile of IDL Biotech AB provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of IDL Biotech AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

IDL Biotech AB – Key Information
IDL Biotech AB – Overview
IDL Biotech AB – Key Employees
IDL Biotech AB – Key Employee Biographies
IDL Biotech AB – Key Operational Heads
IDL Biotech AB – Major Products and Services
IDL Biotech AB – History
IDL Biotech AB – Company Statement
IDL Biotech AB – Locations And Subsidiaries
IDL Biotech AB – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

IDL Biotech AB – Business Description
IDL Biotech AB – Corporate Strategy
IDL Biotech AB – SWOT Analysis
SWOT Analysis – Overview
IDL Biotech AB – Strengths
IDL Biotech AB – Weaknesses
IDL Biotech AB – Opportunities
IDL Biotech AB – Threats
IDL Biotech AB – Key Competitors

Section 3 – Company Financial Performance Charts

IDL Biotech AB – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

IDL Biotech AB, Key Information
IDL Biotech AB, Key Ratios
IDL Biotech AB, Share Data
IDL Biotech AB, Major Products and Services
IDL Biotech AB, History
IDL Biotech AB, Key Employees
IDL Biotech AB, Key Employee Biographies
IDL Biotech AB, Key Operational Heads
IDL Biotech AB, Other Locations
IDL Biotech AB, Subsidiaries
IDL Biotech AB, Key Manufacturing facilities
IDL Biotech AB, Key Competitors
IDL Biotech AB, SWOT Analysis
IDL Biotech AB, Ratios based on current share price
IDL Biotech AB, Annual Ratios
IDL Biotech AB, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

IDL Biotech AB, Performance Chart
IDL Biotech AB, Ratio Charts

★海外企業調査レポート[IDL Biotech AB (IDL B):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nationwide Children’s Hospital-製薬・医療分野:企業M&A・提携分析
    Summary Nationwide Children's Hospital (Nationwide Children's) is a provider of pediatric health care and research services. The hospital offers pediatric services in the areas of gastroenterology, hematology and nutrition, heart care, left lip and palate, oncology ad bone marrow transplantation. It …
  • AltheaDx Inc:医療機器:M&Aディール及び事業提携情報
    Summary AltheaDx Inc (AltheaDx) is a molecular diagnostics company that offers development of pharmacogenetics. The company provides tests such as cardiovascular tests, pain tests, thrombophilia tests and psychiatric tests. It provides diagnostic development, clinical trial and discovery services. A …
  • AIG Asia Pacific Insurance Pte. Ltd.:企業の戦略・SWOT・財務情報
    AIG Asia Pacific Insurance Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary AIG Asia Pacific Insurance Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Synaxon AG:企業の戦略的SWOT分析
    Synaxon AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Callaway Golf Co (ELY):企業の財務・戦略的SWOT分析
    Callaway Golf Co (ELY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • A&E Medical Corp:医療機器:M&Aディール及び事業提携情報
    Summary A&E Medical Corp (A&E Medical), a subsidiary of Vance Street Capital LLC, is a medical device company that manufactures and distributes surgical equipment. The company offers products such as temporary cardiac pacing wires, sternotomy sutures, lluminated vein harvest retractors, electrosurgi …
  • Acobiom:企業の製品パイプライン分析2018
    Summary Acobiom is a biotechnology company that specializes in biomarker discovery and development of innovative diagnostics. The company undertakes the discovery of RNA and DNA biomarkers, which finds application in the areas of disease detection and classification, patient stratification, companio …
  • Dermira Inc (DERM):企業の財務・戦略的SWOT分析
    Summary Dermira Inc (Dermira) is a biopharmaceutical company that identifies, develops and commercializes therapeutic solutions for the treatment of dermatologic diseases, such as hyperhidrosis, acne vulgaris and atopic dermatitis. The company’s product includes QBREXZA (glycopyrronium) cloth, an an …
  • Sfinks Polska S.A.:企業の戦略・SWOT・財務分析
    Sfinks Polska S.A. - Strategy, SWOT and Corporate Finance Report Summary Sfinks Polska S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Bertelsmann SE & Co. KGaA:企業の戦略・SWOT・財務情報
    Bertelsmann SE & Co. KGaA - Strategy, SWOT and Corporate Finance Report Summary Bertelsmann SE & Co. KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • CBRE Group, Inc.:企業の戦略・SWOT・財務分析
    CBRE Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary CBRE Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Petratherm Ltd (PTR):電力:M&Aディール及び事業提携情報
    Summary Petratherm Ltd (Petratherm) is a renewable energy company that carries out the business of exploration and development of emission-free geothermal energy projects. The company holds interest in Paralana Geothermal Energy Project located 600 km north of the city of Adelaide in South Australia …
  • PRA Health Sciences Inc (PRAH):企業の財務・戦略的SWOT分析
    Summary PRA Health Sciences Inc (PRA) is a contract research organization (CRO) which provides outsourced clinical development and data solution services. The company offers asset valuation, regulatory and drug development consulting, risk-based monitoring, site identification and selection, medical …
  • PCI Pharma Services:製薬・医療:M&Aディール及び事業提携情報
    Summary PCI Pharma Services (PCI) is a pharmaceutical service provider that offers clinical, manufacturing and packaging solutions. The company offers clinical services such as clinical supplies management, clinical planning and support, project management, IVRS-IWRS, support services and data acces …
  • Unit Corp (UNT):企業の財務・戦略的SWOT分析
    Summary Unit Corp (Unit) is a diversified energy company that offers exploration and production of oil and natural gas. The company offers acquisition of producing oil and natural gas properties, contract drilling of onshore oil and natural gas wells, and gathering and processing of natural gas. It …
  • Pharmacyclics LLC:企業の戦略的SWOT分析
    Pharmacyclics LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Companhia Energetica de Minas Gerais – CEMIG:企業の戦略・SWOT・財務分析
    Companhia Energetica de Minas Gerais - CEMIG - Strategy, SWOT and Corporate Finance Report Summary Companhia Energetica de Minas Gerais - CEMIG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Neiman Marcus Group LTD LLC:企業の戦略・SWOT・財務分析
    Neiman Marcus Group LTD LLC - Strategy, SWOT and Corporate Finance Report Summary Neiman Marcus Group LTD LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Bosch Sensortec GmbH:企業の戦略的SWOT分析
    Bosch Sensortec GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • GamaMabs Pharma SA-製薬・医療分野:企業M&A・提携分析
    Summary GamaMabs Pharma SA (GamaMabs) is a clinical-stage immuno-oncology company developing optimized therapeutic antibodies for the treatment of cancer. Its lead product candidate GM102, is an anti-AMHR2, Emabling engineered humanized mAb product targeting the receptor of anti-Mullerian hormone (A …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆